Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Michael Tilby

Newcastle AuthorsTitleYearFull text
Nidal Boulos
Dr Michael Tilby
Professor Deborah Tweddle
Professor John Lunec
Identification and characterisation of STMN4 and ROBO2 gene involvement in neuroblastoma cell differentiation2013
Dr Ian Cowell
Dr Michael Tilby
Emerita Professor Caroline Austin
An overview of the visualisation and quantitation of low and high MW DNA adducts using the trapped in agarose DNA immunostaining (TARDIS) assay2011
Emerita Professor Caroline Austin
Dr Ian Cowell
Dr Michael Tilby
Visualisation and quantitation of DNA adducts using the Trapped in Agarose DNA immunostaining (TARDIS) assay2010
Dr Michael Tilby
Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells2009
Dr Michael Tilby
Involvement of the HER2 pathway in repair of DNA damage produced by chemotherapeutic agents2009
Dr Celine Roche
Professor Steve Wedge
Emeritus Professor Herbie Newell
Dr Michael Tilby
The kinase inhibitor O6-cyclohexylmethylguanine (NU2058) potentiates the cytotoxicity of cisplatin by mechanisms that are independent of its effect upon CDK22009
Andrew Jobson
Dr Elaine Willmore
Dr Michael Tilby
Emerita Professor Caroline Austin
Effect of phenazine compounds XR11576 and XR5944 on DNA topoisomerases2008
Dr Michael Tilby
Substituted β-cyclodextrin and calix[4]arene as encapsulatory vehicles for platinum(II)-based DNA intercalators2008
Professor Gareth Veal
Julie Errington
Dr Michael Tilby
Professor Alan Boddy
Adaptive dosing and platinum-DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours2007
Dr Ian Cowell
Dr Nicola Sunter
Emerita Professor Caroline Austin
Emeritus Professor Barbara Durkacz
Dr Michael Tilby
γH2AX foci form preferentially in euchromatin after ionising-radiation2007
Jessie Jeyapalan
Dr Gabriele Saretzki
Alan Leake
Dr Michael Tilby
Professor Thomas von Zglinicki
Neuroblastoma cell apoptosis induction after cisplatin treatment is not telomere–dependent2006
Jessie Jeyapalan
Dr Gabriele Saretzki
Alan Leake
Dr Michael Tilby
Professor Thomas von Zglinicki
Tumour-cell apoptosis after cisplatin treatment is not telomere dependent2006
Annie Parry
Dr Michael Tilby
Professor Dianne Ford
Emerita Professor Suzanne Cholerton
Professor Andrew Pearson
et al.		Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer2005
Dr Ian Cowell
Emeritus Professor Barbara Durkacz
Dr Michael Tilby
Sensitization of breast carcinoma cells to ionizing radiation by small molecule inhibitors of DNA-dependent protein kinase and ataxia telangiectsia mutated2005
Dr Emma Meczes
Ali Azim-Araghi
Dr Michael Tilby
Specific adducts recognised by a monoclonal antibody against cisplatin-modified DNA2005
12345